Die Autoren der bearbeiteten Übersetzung aus dem Englischen sind:
M. H. Pittler1 ,
A. Blümle1 , J. J. Meerpohl1,2 , G. Antes1
1 Deutsches Cochrane Zentrum, Abteilung
für Medizinische Biometrie und Statistik,
Universitätsklinikum Freiburg, Freiburg
2 Pädiatrische Hämatologie und Onkologie,
Zentrum für Kinder- und Jugendmedizin,
Universitätsklinikum Freiburg, Freiburg
Literatur
1
Begg C, Cho M, Eastwood S. et al .
Improving the quality of reporting of randomized
controlled trials. The CONSORT statement.
JAMA.
1996;
276
637-639
2
Boutron I, Moher D, Altman D G, Schulz K F, Ravaud P.
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment:
explanation and elaboration.
Ann Intern Med.
2008;
148
295-309
3
Campbell M K, Elbourne D R, Altman D G.
CONSORT statement: extension to cluster
randomised trials.
BMJ.
2004;
328
702-708
4
Chan A W, Hrobjartsson A, Haahr M T, Gotzsche P C, Altman D G.
Empirical evidence for selective
reporting of outcomes in randomized trials: comparison of protocols
to published articles.
JAMA.
2004;
291
2457-2465
5
De Angelis C, Drazen J M, Frizelle F A. et al .
Clinical trial registration:
a statement from the International Committee of Medical Journal Editors.
Ann Intern Med.
2004;
141
477-478
6
Dwan K, Altman D G, Arnaiz J A. et al .
Systematic review of the
empirical evidence of study publication bias and outcome reporting
bias.
PLoS ONE.
2008;
3
e3081
7
Gagnier J J, Boon H, Rochon P. et
al .
Reporting randomized, controlled trials of herbal
interventions: an elaborated CONSORT statement.
Ann Intern
Med.
2006;
144
364-367
8
Glasziou P, Meats E, Heneghan C, Shepperd S.
What is missing from
descriptions of treatment in trials and reviews?.
BMJ.
2008;
336
1472-1474
9
Hollis S, Campbell F.
What is meant by intention
to treat analysis? Survey of published randomised controlled trials.
BMJ.
1999;
319
670-674
10
Hopewell S, Clarke M, Moher D. et al .
CONSORT for reporting randomised trials
in journal and conference abstracts.
Lancet.
2008;
371
281-283
11
Hopewell S, Clarke M, Moher D. et al .
CONSORT for reporting randomized controlled trials
in journal and conference abstracts: explanation and elaboration.
PLoS Med.
2008;
5
e20
12
Ioannidis J P, Evans S J, Gotzsche P C. et al .
Better reporting of harms
in randomized trials: an extension of the CONSORT statement.
Ann Intern
Med.
2004;
141
781-788
13
Lexchin J, Bero L A, Djulbegovic B, Clark O.
Pharmaceutical industry
sponsorship and research outcome and quality: systematic review.
BMJ.
2003;
326
1167-1170
14
Moher D, Hopewell S, Schulz K F. et al .
CONSORT 2010 explanation and elaboration:
updated guidelines for reporting parallel group randomised trials.
BMJ.
2010;
340
c869
15
Moher D, Schulz K F, Altman D G, Gruppe f dC.
Das
CONSORT Statement: Überarbeitete Empfehlungen zur Qualitätsverbesserung von
Reports randomisierter Studien im Parallel-Design.
Dtsch
med Wochenschr.
2004;
129
T16-T20
16
Montori V M, Devereaux P J, Adhikari N K. et al .
Randomized trials
stopped early for benefit: a systematic review.
JAMA.
2005;
294
2203-2209
17
Nuovo J, Melnikow J, Chang D.
Reporting number needed to treat and absolute risk reduction
in randomized controlled trials.
JAMA.
2002;
287
2813-2814
18
Piaggio G, Elbourne D R, Altman D G, Pocock S J, Evans S J.
Reporting of noninferiority and equivalence
randomized trials: an extension of the CONSORT statement.
JAMA.
2006;
295
1152-1160
19
Sackett D L.
Commentary: Measuring the success of blinding in RCTs: don’t,
must, can’t or needn’t?.
Int J Epidemiol.
2007;
36
664-665
20
Schulz K F, Altman D G, Moher D. for the CONSORT Group .
CONSORT 2010 Statement:
updated guidelines for reporting parallel group randomised trials.
BMJ.
2010;
340
c332
21
Schulz K F, Grimes D A.
Blinding in
randomised trials: hiding who got what.
The Lancet.
2002;
359
696-700
22
Zwarenstein M, Treweek S, Gagnier J J. et al .
Improving the reporting of pragmatic trials: an
extension of the CONSORT statement.
BMJ.
2008;
337
a2390
Dr. Gerd Antes
Deutsches Cochrane Zentrum Abteilung für
Medizinische Biometrie und Statistik Institut
für Medizinische Biometrie und Medizinische Informatik Universitätsklinikum
Freiburg
Berliner Allee 29
79110 Freiburg
eMail: antes@cochrane.de